Firefly Neuroscience annual net debt
2018
2019
2020
2021
2022
2023
2024
Firefly Neuroscience Net Debt Growth & History (AIFF)
Firefly Neuroscience's net debt was −$1.1M for fiscal 2024.
View full Firefly Neuroscience company overviewFirefly Neuroscience annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$1.1M | −$733,939 | — |
| 2023 | 2023-12-31 | −$382,061 | −$158,100 | — |
| 2022 | 2022-12-31 | −$223,961 | $4.0M | — |
| 2021 | 2021-12-31 | −$4.2M | −$2.9M | — |
| 2020 | 2020-12-31 | −$1.4M | −$472,673 | — |
| 2019 | 2019-12-31 | −$889,892 | $1.1M | — |
| 2018 | 2018-12-31 | −$2.0M | — | — |
Firefly Neuroscience quarterly net debt
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$1.1M | −$733,939 | — |
| Q2 2024 | 2024-06-30 | −$204,527 | −$271,990 | — |
| Q1 2024 | 2024-03-31 | −$484,546 | −$126,640 | — |
| Q4 2023 | 2023-12-31 | −$382,061 | −$158,100 | — |
| Q3 2023 | 2023-09-30 | −$523,713 | $441,110 | — |
| Q2 2023 | 2023-06-30 | $67,463 | $41,129 | +156.18% |
| Q1 2023 | 2023-03-31 | −$357,906 | $2.0M | — |
| Q4 2022 | 2022-12-31 | −$223,961 | $4.0M | — |
| Q3 2022 | 2022-09-30 | −$964,823 | $2.4M | — |
| Q2 2022 | 2022-06-30 | $26,334 | −$249,483 | −90.45% |
| Q1 2022 | 2022-03-31 | −$2.3M | $201,012 | — |
| Q4 2021 | 2021-12-31 | −$4.2M | −$2.9M | — |
| Q3 2021 | 2021-09-30 | −$3.4M | −$2.0M | — |
| Q2 2021 | 2021-06-30 | $275,817 | $1.1M | — |
| Q1 2021 | 2021-03-31 | −$2.5M | −$1.9M | — |
| Q4 2020 | 2020-12-31 | −$1.4M | −$472,673 | — |
| Q3 2020 | 2020-09-30 | −$1.4M | −$477,306 | — |
| Q2 2020 | 2020-06-30 | −$862,216 | $475,200 | — |
| Q1 2020 | 2020-03-31 | −$626,486 | $954,729 | — |
| Q4 2019 | 2019-12-31 | −$889,892 | $1.1M | — |
| Q3 2019 | 2019-09-30 | −$919,607 | — | — |
| Q2 2019 | 2019-06-30 | −$1.3M | — | — |
| Q1 2019 | 2019-03-31 | −$1.6M | — | — |
| Q4 2018 | 2018-12-31 | −$2.0M | — | — |
Firefly Neuroscience net debt trends
Over the last five fiscal years, Firefly Neuroscience's net debt decreased from −$889,892 to −$1.1M, a change of −$226,108. The latest reported quarter, Q4 2024, shows −$1.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Firefly Neuroscience source filings ↗